Compare OVLY & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OVLY | SMTI |
|---|---|---|
| Founded | 1990 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 288.3M | 322.2M |
| IPO Year | 2008 | 2008 |
| Metric | OVLY | SMTI |
|---|---|---|
| Price | $33.55 | $35.09 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $35.00 |
| AVG Volume (30 Days) | 11.6K | ★ 159.8K |
| Earning Date | 10-26-2026 | 11-11-2026 |
| Dividend Yield | ★ 2.24% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.25 | N/A |
| Revenue | N/A | ★ $15,586,976.00 |
| Revenue This Year | N/A | $13.07 |
| Revenue Next Year | N/A | $14.23 |
| P/E Ratio | $26.74 | ★ N/A |
| Revenue Growth | N/A | ★ 32.47 |
| 52 Week Low | $25.44 | $16.05 |
| 52 Week High | $35.97 | $35.34 |
| Indicator | OVLY | SMTI |
|---|---|---|
| Relative Strength Index (RSI) | 46.52 | 63.27 |
| Support Level | $32.78 | $34.63 |
| Resistance Level | $34.22 | $35.34 |
| Average True Range (ATR) | 0.82 | 0.21 |
| MACD | -0.06 | -0.08 |
| Stochastic Oscillator | 31.49 | 52.81 |
Oak Valley Bancorp is a bank holding company that operates through Oak Valley Community Bank (the Bank). The Bank offers a complement of business checking and savings accounts for its business customers. The Bank also offers commercial and real estate loans, as well as lines of credit. In addition, the bank provides other services for both individuals and businesses including online banking, remote deposit capture, mobile banking, merchant services, night depository, extended hours, wire transfer of funds, note collection, and automated teller machines in a national network. Its primary source of revenue is net interest income.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.